(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTraders Line Up for ‘Once-in-a-Generation’ Emerging Markets BetSingapore’s $200,000 Toyotas Fuel Angst Over Wealth GapHouthi Hit on Russian Fuel Has Traders Recalculating RisksThree US Troops Killed in Attack Tied to Iran-Backed GroupsTrump’s Cash Stockpile at Risk From $450 M
(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTraders Line Up for ‘Once-in-a-Generation’ Emerging Markets BetBlackstone Is Building a $25 Billion Empire of Power-Hungry Data CentersTrump Cash Stockpile at Risk From $450 Million Dual VerdictsMusk Says First Human Patient Has Received Brain ImplantAmazon Drops iRobot Deal;
(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTrump Risks Losing More Than Half of Swing-State Voters If Found GuiltyMusk’s $55 Billion Pay Package Voided, Threatening World’s Biggest FortuneS&P 500 Has Its Worst Fed-Decision Day Since March: Markets WrapByron Allen’s Latest Takeover Bid: Paramount for $14 BillionNY Commu